End products of lipid peroxidation in erythrocyte membranes in Alzheimer's disease

Cell Biochemistry and Function

Volumn 30, Issue 3, 2012, Pages 205-210

  Skoumalová, Alice ^a   Mádlová, Pavla ^b   Topinková, Eva ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Alzheimer's disease; Erythrocytes; Lipid peroxidation; Lipofuscin like pigments; Oxidative stress

Indexed keywords

FREE RADICAL; LIPOFUSCIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE MEMBRANE; FEMALE; FLUORESCENCE SPECTROSCOPY; HUMAN; IN VITRO STUDY; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; ERYTHROCYTE MEMBRANE; FEMALE; HUMANS; LIPID PEROXIDATION; LIPOFUSCIN; MALE; OXIDATIVE STRESS;

EID: 84859445852     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1836     Document Type: Article

References (24)

1. Humpel C. Identifying and validating biomarkers for Alzheimer's disease. Trends Biotechnol 2011; 29: 26-32.
2. Bonda DJ, Wang X, Perry G, et al. Oxidative stress in Alzheimer disease: A possibility for prevention. Neuropharmacology 2010; 59: 290-294.
3. Swerdlow RH, Khan SM. The Alzheimer's disease mitochondrial cascade hypothesis: an update. Exp Neurol 2009; 218: 308-315.
4. Butterfield DA, Lauderback CM. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress. Free Radic Biol Med 2002; 11: 1050-1060.
5. Ansari MA, Scheff SW. Oxidative stress in the progression of Alzheimer disease in the frontal cortex. J Neuropathol Exp Neurol 2010; 69: 155-167.
6. Chio KS, Tappel AL. Synthesis and characterization of the fluorescent products derived from malonaldehyde and amino acids. Biochemistry 1969; 8: 2821-2826.
7. Wilhelm J, Brzak P, Rejholcova M. Changes of lipofuscin-like pigments in erythrocytes and spleen after whole-body gamma irradiation of rats. Radiat Res 1989; 120: 227-233.
8. Wilhelm J, Herget J. Hypoxia induces free radical damage to rat erythrocytes and spleen: analysis of the flurorescent end-products of lipid peroxidation. Int J Biochem Cell Biol 1999; 31: 671-681.
9. Veselá A, Wilhelm J, Kawaciuk I. Investigation of the role of free radicals damage in patients after transurethral prostatectomy. J Urol 2002; 67: 221-222.
10. Skoumalová A, Rofina J, Schwippelová Z, Gruys E, Wilhelm J. The role of free radicals in canine counterpart of senile dementi of the Alzheimer type. Exp Gerontol 2003; 38: 711-719.
11. Montine TJ, Sidell KR, Crews BC, et al. Elevated CSF prostaglandin E2 levels in patients with probable AD. Neurology 1999; 7: 1495-1498.
12. Bourdel-Marchasson I, Delmas-Beauvieux MC, Peuchant E, et al. Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age Ageing 2001; 30: 235-241.
13. Greilberger J, Koidl C, Greilberger M, et al. Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease. Free Radic Res 2008; 42: 633-638.
14. Mangialasche F, Polidori MC, Monastero R, Ercolani S, Camarda C, Cecchetti R, Mecocci P. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment. Ageing Res Rev 2009; 8: 285-305.
15. Farrall AJ, Wardlaw JM. Blood-brain barrier: ageing and microvascular disease-systematic review and meta-analysis. Neurobiol Aging 2009; 30: 337-352.
16. Skoumalová A, Ivica J, Šantorová P, Topinková E, Wilhelm J. The lipid peroxidation products as possible markers of Alzheimer's disease in blood. Exp Gerontol 2011; 46: 38-42.
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
18. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
19. Román GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the National Institute of Neurological Communicative Disorders and StrokeAssociation Internationale pour la Recherche' et l'Enseignement en Nourosciences (NINCDS-AIREN) International Workshop. Neurology 1993; 43: 250-260.
20. Goldstein BD, McDonagh EM. Spectrofluorescent detection of in vivo red cell lipid peroxidation in patients treated with diaminodiphenylsulfone. J Clin Invest 1996; 57: 1302-1307.
21. Mangialasche F, Kivipelto M, Mecocci P, et al. High plasma levels of vitamin E forms and reduced Alzheimer's disease risk in advanced age. J Alzheimers Dis 2010; 20: 1029-1037.
22. Corrigan FM, Horrobin DF, Skinner ER, Besson JAO, Cooper MB. Abnormal content of n-6 and n-3 long-chain unsaturated fatty acids in the phosphoglycerides and cholesterol esters of parahippocampal cortex from Alzheimer's disease patients and its relationship to acetyl CoA content. Int J Biochem Cell Biol 1998; 30: 197-207.
23. Nakada T, Kwee IL, Ellis WG. Membrane fatty acid composition shows delta-6-desaturase abnormalities in Alzheimer's disease. Neuroreport 1990; 1: 153-155.
24. Söderberg M, Edlund C, Kristensson K, Dallner G. Fatty acid composition of brain phospholipids in aging and in Alzheimer disease. Lipids 1991; 26: 421-425.